首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1532495

胆固醇测试服务市场规模- 按测试类型（总胆固醇、HDL、LDL、三酸甘油酯）、产品类型（测试套件、试纸）、应用（心血管疾病、糖尿病、肥胖）、年龄层、服务提供者和全球预测，2024 年 - 2032

Cholesterol Testing Services Market Size - By Test Type (Total Cholesterol, HDL, LDL, Triglyceride), Product Type (Testing Kits, Strips), Application (Cardiovascular Disease, Diabetes, Obesity), Age Group, Service Provider & Global Forecast, 2024 - 2032

出版日期: 2024年05月21日 | 出版商:

Global Market Insights Inc. | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于心血管疾病 (CVD) 盛行率不断上升以及人们健康意识不断增强，胆固醇检测服务市场规模预计 2024 年至 2032 年复合年增长率为 8.1%。根据世界卫生组织的数据，CVD 是世界上最主要的死亡原因，每年夺走约 1,790 万人的生命。随着肥胖、糖尿病和高血压等与生活方式相关的疾病变得普遍，人们更倾向于定期进行胆固醇筛检，以主动管理自己的健康。

更准确、更快速和用户友好的胆固醇检测方法的开发也提高了患者的可及性和便利性，鼓励更频繁的检测。将胆固醇检测服务纳入常规健康检查和健康计划（无论是在临床环境中还是透过家庭检测套件）也将扩大其可用性和吸引力。

市场分为测试类型、产品类型、应用、年龄层、服务提供者和地区。

根据测试类型，三酸甘油酯测试领域的胆固醇测试服务市场预计到 2032 年将大幅成长。高三酸甘油酯水平通常与心臟病、中风和其他代谢紊乱的风险增加有关，因此监测对于预防保健至关重要。

由于高血脂症盛行率不断上升，高血脂应用领域的胆固醇检测服务产业将在 2024 年至 2032 年期间产生可观的收入。管理高血脂需要定期监测这些脂质水平，以预防心血管疾病和其他相关的健康併发症。随着越来越多的人被诊断出患有高血脂症，对胆固醇检测服务的需求也将增加，以促进早期发现和持续管理。

由于心血管疾病和生活方式相关健康问题日益流行，亚太地区胆固醇检测服务市场预计到 2032 年将呈现良好的成长速度。快速的城市化和饮食习惯的改变导致人口胆固醇水平升高，进一步需要定期监测胆固醇。促进常规健康检查的政府措施和公共卫生运动也促进了区域产业的成长。

产业生态系统分析
产业影响力
- 成长动力
  - 心血管疾病盛行率上升
  - 预防保健意识不断增强
  - 老年人口增加
- 产业陷阱与挑战
  - 监管和品质保证挑战
  - 与测试服务相关的高成本
成长潜力分析
技术景观
监管环境
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按测试类型，2021 - 2032 年

主要趋势
总胆固醇测试
高密度脂蛋白（HDL）胆固醇测试
低密度脂蛋白（LDL）胆固醇测试
三酸甘油酯测试
其他测试

第 6 章：市场估计与预测：按产品类型，2021 - 2032 年

主要趋势
测试套件
测试条
其他产品类型

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
心血管疾病
糖尿病
肥胖
高血脂症
其他应用

第 8 章：市场估计与预测：按年龄划分，2021 - 2032

主要趋势
老年科
成人
儿科

第 9 章：市场估计与预测：按服务提供者划分，2021 - 2032 年

主要趋势
医院和诊所
诊断实验室
门诊护理中心
其他服务提供者

第 10 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 11 章：公司简介

Abbott Laboratories
Accu Reference Medical Lab, LLC
Atherotech Diagnostics Lab
Bio-Reference Laboratories, Inc.
Boston Heart Diagnostics Corporation
Cell Biolabs Inc.
Clinical Reference Laboratory, Inc.
Eurofins Scientific
Mayo Clinic Laboratories
Quest Diagnostics Incorporated
Randox Laboratories Limited
Sonic Healthcare Limited
SpectraCell Laboratories Inc.
SYNLAB Holding Deutschland GmbH
Thermo Fisher Scientific Inc.

简介目录

Product Code: 9548

Cholesterol testing services market size is estimated to register 8.1% CAGR from 2024 to 2032 driven by the increasing prevalence of cardiovascular diseases (CVDs) and the growing health awareness among the population. As per WHO, CVDs are the world's leading cause of death, claiming approximately 17.9 million lives annually. As lifestyle-related conditions, such as obesity, diabetes, and high blood pressure have become common, individuals are more inclined to seek regular cholesterol screenings to manage their health proactively.

The development of more accurate, rapid, and user-friendly cholesterol testing methods is also enhancing the accessibility and convenience for patients, encouraging more frequent testing. The integration of cholesterol testing services into routine health check-ups and wellness programs, both in clinical settings and through home testing kits will also broaden their availability and appeal.

The market is classified into test type, product type, application, age group, service provider, and region.

Based on test type, the cholesterol testing services market from the triglyceride tests segment is anticipated to witness substantial growth through 2032. This is due to the strong need to provide crucial insights into the overall lipid profile, which is essential for comprehensive cardiovascular risk assessment. High triglyceride levels are often associated with increased risk of heart disease, stroke, and other metabolic disorders, making monitoring vital for preventive healthcare.

Cholesterol testing services industry from the hyperlipidemia application segment will generate notable revenue during 2024-2032 owing to the rising prevalence of hyperlipidemia. Managing hyperlipidemia requires regular monitoring of these lipid levels to prevent cardiovascular diseases and other associated health complications. As more individuals are diagnosed with hyperlipidemia, the demand for cholesterol testing services will also increase to facilitate early detection and ongoing management.

Asia Pacific cholesterol testing services market is slated to depict decent growth rate through 2032 backed by the increasing prevalence of cardiovascular diseases and lifestyle-related health issues. Rapid urbanization and changing dietary habits are contributing to higher cholesterol levels among the population, further necessitating regular cholesterol monitoring. Government initiatives and public health campaigns for promoting routine health screenings are also adding to the regional industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of cardiovascular diseases
  - 3.2.1.2 Growing awareness of preventive healthcare
  - 3.2.1.3 Increasing geriatric population
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Regulatory and quality assurance challenges
  - 3.2.2.2 High cost associated with the testing services
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Test Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Total cholesterol tests
5.3 High density lipoprotein (HDL) cholesterol tests
5.4 Low density lipoprotein (LDL) cholesterol tests
5.5 Triglyceride tests
5.6 Other tests

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Testing kits
6.3 Testing strips
6.4 Other product types

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Cardiovascular diseases
7.3 Diabetes
7.4 Obesity
7.5 Hyperlipidemia
7.6 Other applications

Chapter 8 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Geriatric
8.3 Adult
8.4 Pediatric

Chapter 9 Market Estimates and Forecast, By Service Provider, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Ambulatory care centers
9.5 Other service providers

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Netherlands
- 10.3.7 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
- 10.4.6 Rest of Asia Pacific
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
- 10.5.4 Rest of Latin America
10.6 Middle East and Africa
- 10.6.1 Saudi Arabia
- 10.6.2 South Africa
- 10.6.3 UAE
- 10.6.4 Rest of Middle East and Africa